8 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
• Hepatitis A virus ... • Hepatitis B virus ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
• Hepatitis A virus ... • Hepatitis B virus ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
Coverage of common antibiotics ... define the type of infection ... , then review prior ... ampicillin #management ... #antibiogram #pharmacology
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
Flutycosine - Antibiotics ... B for initial management ... severe fungal infections ... #Pharmacology #Antibiotics ... #Review #Overview
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... expansion and relief ... care (intravenous antibiotics ... #Malignant #Pleural
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Herpes Simplex Virus ... (HSV) Infections ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
Varicella Zoster Virus ... (VZV) Infections ... because of vaccine virus ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... known or suspected malignant ... expansion and relief ... care (intravenous antibiotics ... #Management #Pleural